Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom
Bioavailability study of an innovative Orobuccal formulation of glutathione
Use-by dates for B12 I posted recently about a three month decline and symptom return as my B12 batch approached its...
PMID 32956545
Enzymatic degradation of the glycocalyx is mediated by catabolic enzymes, catabolites, metalloproteinases, matrix metalloproteinases (MMPs), disintegrin and metalloproteinase domain-containing proteins (ADAMs), heparanase-1, hyaluronidase, and GPI-specific PLC AMs (6163)
This includes innovations in production, quality control, and formulation science, as well as the application of advanced technologies such as nanotechnology to protect and enhance the absorption of these compounds, thereby improving their therapeutic potential